April is Stress Awareness Month — a timely reminder that stress isn’t just a mental health issue. For your patients, chronic stress may be the hidden force quietly dismantling their entire hormonal ecosystem. And yet, most providers never make that connection. They treat fatigue, anxiety, weight gain, and the sleep disruption as separate problems. They reach for antidepressants, sleep aids, and weight loss protocols — all while the real culprit goes unaddressed.

That culprit? Cortisol dysregulation and HPA axis dysfunction — conditions that are extraordinarily common, frequently missed, and absolutely treatable when a provider knows what to look for.

Cortisol Does Far More Than Manage Stress

Most providers think about cortisol only at the extremes — Cushing’s disease when it’s dangerously high, or Addison’s disease when it’s critically low. But between those extremes lies a vast clinical gray zone where millions of patients are struggling, and where conventional medicine offers very little guidance.

Cortisol is a master regulator. It governs:

• Energy production and blood sugar metabolism
• Fluid balance and blood pressure regulation
• Immune function and inflammatory response
• Mood, memory formation, and cognitive clarity
• Fat storage — particularly abdominal weight gain

When cortisol is chronically dysregulated — too high, too low, or erratic — every system on that list is affected. And because the adrenals also produce DHEA and pregnenolone, the ripple effects extend far beyond energy and immunity. They reach directly into your patient’s sex hormone balance.

How Chronic Stress Steals Sex Hormones

Here’s what the textbooks don’t teach: cortisol and your sex hormones share the same raw materials. Pregnenolone and progesterone are steroidogenic intermediates — the building blocks used to produce estrogen, testosterone, and cortisol. Under chronic stress, the body prioritizes cortisol production above all else. When those shared intermediates are diverted to fuel the stress response, there simply isn’t enough left to maintain healthy levels of estrogen, progesterone, and testosterone.

A quick note on terminology: Catecholamines are hormones produced primarily by the adrenal glands — the main ones being adrenaline (epinephrine), noradrenaline (norepinephrine), and dopamine. Released during the body’s fight-or-flight response, they increase heart rate, blood pressure, and mental alertness while redirecting blood flow away from the skin and toward the major organs. In chronic stress, sustained catecholamine output compounds the damage done by cortisol dysregulation.

The downstream results are predictable and clinically significant:

• Lower estrogen + elevated catecholamines = worsened hot flashes
• Lower progesterone + elevated catecholamines = poor sleep, anxiety, and irritability
• Lower testosterone + elevated catecholamines = decreased libido and sexual performance

The compounding effect is significant: high cortisol also directly blocks progesterone’s ability to oppose estrogen, suppresses testosterone production, and interferes with testosterone at the receptor level. Meanwhile, elevated cortisol inhibits the conversion of T4 to T3, adding thyroid dysfunction to the mix. Providers who treat these symptoms in isolation — without understanding the cortisol connection — will never get their patients to optimal.

Three Things Providers Are Getting Wrong

1. 1. Testing cortisol with a single serum draw.  A single serum cortisol measurement is one of the most clinically limited tests in hormone medicine. It shows bound cortisol — not free, bioavailable cortisol — and it captures only a single moment in a hormone that follows a diurnal rhythm throughout the day. It cannot detect whether a patient is stuck in the alarm phase (elevated cortisol), the resistance phase (erratic cortisol with possible low DHEA), or the exhaustion phase (low cortisol, low DHEA). The standard of care for identifying HPA axis dysfunction is a 4-point salivary cortisol test or dried urine adrenal testing, which maps the full diurnal pattern and provides critical metabolite information.
   2. Treating symptoms without addressing the root cause.  When a patient presents with anxiety, insomnia, weight gain, and low libido, a conventional workup may yield “normal” labs and a prescription for each symptom. A trained provider recognizes these as a cluster that points directly to HPA axis dysfunction. Without addressing cortisol, even well-designed hormone replacement protocols will underperform — because low cortisol decreases the production of steroid hormone receptors and reduces hormone absorption overall.
   3. Missing the adrenal-thyroid-hormone connection.  HPA axis dysfunction rarely travels alone. Cortisol dysregulation overlaps significantly with hypothyroid symptoms, disrupts sex hormone balance, drives insulin resistance, and depresses immune function. Treating adrenals first — or concurrently — is essential to achieving true hormonal optimization. Providers who skip this step will find that their patients plateau or regress despite seemingly appropriate hormone protocols.

A Targeted Approach: Protocols for Every Cortisol Pattern

Effective treatment begins with pattern identification — because high, low, and fluctuating cortisol each require a distinct clinical approach.

High Cortisol (Alarm Phase):

The goal is to dampen HPA axis activation and reduce the cortisol burden. Key nutraceutical interventions include phosphatidylserine, ashwagandha, holy basil, magnesium, L-theanine, and Relora. These work synergistically to modulate the stress response, support sleep quality, and reduce the anxious, “tired but wired” presentation so common in this phase. Lifestyle foundations — blood sugar stabilization, caffeine reduction, and evening wind-down protocols — are non-negotiable.

Low Cortisol (Exhaustion Phase):

Recovery here is slower and requires adrenal rebuilding. Adrenal glandulars, licorice root extract (with caution in patients with elevated BP), vitamin C, B5, and rhodiola form the foundation of support. In more significant cases, low-dose hydrocortisone (5–15 mg in divided doses to mimic natural diurnal rhythm) may be warranted as a short-term prescription intervention. Recovery can take 12–36 months and requires patient education and ongoing monitoring.

Fluctuating Cortisol (Resistance Phase):

The most clinically complex pattern, fluctuating cortisol, calls for an adaptogen-based combination approach — ashwagandha, rhodiola, and holy basil — alongside B6 and supporting nutrients tailored to the patient’s symptom pattern. Because this presentation is inherently variable, individualization is key. Combination professional-grade formulas designed for mixed adrenal patterns are often the most effective and practical starting point.

The Clinical Competency Most Providers Never Received

HPA axis dysfunction is one of the most prevalent and most overlooked conditions in modern medicine. It hides behind “normal” lab results, masquerades as depression or burnout, and silently undermines every hormone protocol that doesn’t account for it. The providers who get patients truly well are the ones who understand that stress isn’t just a lifestyle issue — it’s a hormonal one.

This is exactly the level of clinical depth the BHRT Training Academy builds into every provider we train. Because optimizing hormones without addressing the adrenal foundation isn’t optimization — it’s guesswork.

Your patients deserve a provider who sees the whole picture. This Stress Awareness Month, that starts with understanding what cortisol is really doing — and what it’s taking with it.

If you’re seeing this in your own practice—patients who aren’t responding the way they should, or protocols that feel incomplete—you’re not alone.

This is exactly the kind of clinical gap we focus on inside the Academy—helping providers connect the dots and confidently treat the whole picture.

If you want to learn more about how we approach this, you can schedule a call with our team here.

If you found this helpful, you might also enjoy:

• From Fear to Facts: How the FDA’s Decision Validates the Bioidentical Hormone Revolution
• Hormones & Breast Cancer Risk: Essential Evidence for Providers
• Polycystic Ovarian Syndrome (PCOS): A Comprehensive Management Guide for Healthcare Practitioners